Stay updated with breaking news from Nicolas Tilmans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug discovery specialist Anagenex has sealed a collaboration pact with Nimbus Therapeutics to co-develop small molecule drugs with the help of artificial intelligence (AI).
Check out news from Equiva, PrecisionGx, Wavemaker Three-Sixty Health, Jasper Health, and Anagenex.
The CEO of Anagenex believes that the company's AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!